← GE HealthCare Technologies Inc.

Annual Trend FY 2021 FY 2022 FY 2023 FY 2024 FY 2025
Total Revenue $17.6b
$18.3b +4.30%
$19.6b +6.60%
$19.7b +0.61%
$20.6b +4.84%
Cost of sales $10.4b
$11.2b +7.21%
$11.6b +4.19%
$11.5b -1.40%
$12.4b +7.94%
Gross Profit $7.2b
$7.2b +0.07%
$7.9b +10.35%
$8.2b +3.57%
$8.2b +0.52%
Research and Development Expense $816.0m $1.0b $1.2b $1.3b $1.3b
Selling, General and Administrative Expense $3.6b $3.6b $4.3b $4.3b $4.2b
Amortization of Intangible Assets — $405.0m $362.0m $312.0m $291.0m
Operating Expenses $4.4b $4.7b $5.5b $5.6b $5.5b
Operating Income (Loss) $2.8b
$2.5b -9.77%
$2.4b -3.45%
$2.6b +7.80%
$2.8b +5.26%
Investment Income, Net — ($9.0m) $26.0m ($1.0m) $41.0m
Foreign Currency Transaction Gain (Loss), before Tax — ($88.0m) $16.0m $16.0m ($149.0m)
Gain (Loss) on Investments — ($31.0m) $1.0m ($22.0m) $112.0m
Other Nonoperating Income (Expense) — $62.0m $86.0m $55.0m $157.0m
Income (Loss) from Equity Method Investments — $13.0m $11.0m $8.0m $3.0m
Non-operating benefit (income) costs $3.0m ($5.0m) ($382.0m) ($406.0m) ($288.0m)
Income (Loss) from Continuing Operations before Income Taxes, Domestic — $1.1b $816.0m $593.0m $1.0b
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $2.9b $2.5b $2.4b $2.6b $2.8b
Benefit (provision) for income taxes ($600.0m) ($563.0m) ($743.0m) ($531.0m) ($614.0m)
Net income from continuing operations $2.3b $1.9b $1.6b $2.0b $2.2b
Net Income (Loss) Attributable to Parent $2.2b
$1.9b -14.73%
$1.6b -18.16%
$2.0b +27.10%
$2.1b +4.57%
Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic $2.2b $1.9b $1.4b $2.0b $2.1b
Net Income (Loss) Attributable to Noncontrolling Interest — $51.0m $46.0m $57.0m $70.0m
Deemed preferred stock dividend of redeemable noncontrolling interest $0 $0 ($183.0m) $0 $0
Earnings Per Share, Basic $4.95 $4.22 $3.05 $4.37 $4.56
Earnings Per Share, Diluted $4.95 $4.22 $3.03 $4.34 $4.55
Income (Loss) from Continuing Operations, Per Basic Share — $4 $3 $4 $5
Income (Loss) from Continuing Operations, Per Diluted Share — $4 $3 $4 $5
Common Stock, Dividends, Per Share, Declared $0.00 $0.00 $0.12 $0.12 $0.14
Weighted Average Number of Shares Outstanding, Basic 454.0m 454.0m 455.0m 456.0m 456.0m
Basic (in shares) $454.0m $454.0m $455.0m $456.0m $456.0m
Diluted (in shares) $454.0m $454.0m $458.0m $459.0m $458.0m
Weighted Average Number of Shares Outstanding, Diluted 454.0m 454.0m 458.0m 459.0m 458.0m
Additional Financial Items
Goodwill, Impairment Loss — $0 — $0 $0
Interest and other financial charges – net $40.0m $77.0m $542.0m $504.0m $440.0m
Other (income) expense – net ($123.0m) ($62.0m) ($86.0m) ($55.0m) ($157.0m)
Income (loss) from discontinued operations, net of taxes $18.0m $18.0m ($4.0m) $0 $0
Net (income) loss attributable to noncontrolling interests ($46.0m) ($51.0m) ($46.0m) ($57.0m) ($70.0m)
Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent — $1.9b $1.6b $2.0b $2.1b
Income (Loss) from Continuing Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $2.3b $1.9b $1.6b $2.0b $2.2b
Income (Loss) from Discontinued Operations, Net of Tax, Including Portion Attributable to Noncontrolling Interest $18.0m $18.0m ($4.0m) $0 $0
Net Periodic Defined Benefits Expense (Reversal of Expense), Excluding Service Cost Component $3.0m ($5.0m) ($382.0m) ($406.0m) ($288.0m)

Amounts are shown in USD as reported in each fiscal year filing.

Values abbreviated: b = billions, m = millions, k = thousands. Per share data in USD.